BofA Securities reiterated its Buy rating on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN), with a steady price target of GBP145.00. The firm's positive stance is based on the pharmaceutical giant's ...
While the UK’s growth outlook has suffered a significant setback relative to the more optimistic tone that was prevalent in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback